Contact Us

COVID-19 (SARS Co-V-2) Update: Focus on Epidemiology, Transmission, Risk Factors for Severe Illness, Persistence of Symptoms, and Vaccine Development

Authored by: David Jay Weber, M.D., M.P.H., FSHEA, FIDSA, FRSM (London)

This course qualifies for 1 CE / 1 IPU and corresponds to the following Infection Prevention Unit (IPU) domain(s):

  • Identification of Infectious Disease Processes
  • Surveillance and Epidemiologic Investigation
  • Preventing/Controlling the Transmission of Infectious Agents
  • Management and Communication

At the end of this course, the learner will be able to:

  • Discuss new information on SARS Co-V-2:
  • Discuss current incidence and prevalence:
  • Describe the impact of COVID-19 Infection: UNC Medical Center
  • Discuss transmission data: Overview, travel concerns, environment, aerosols; prevention of acquisition
  • Describe risk factors for severe disease: Surgery, age, underlying health conditions
  • Discuss the duration of infectivity and discontinuation of precautions
  • Describe current treatment guidelines: IDSA, NIH, UNC
  • Discuss the development of COVID vaccines and provide an update on current status

Course Lessons

1
Video Lesson
COVID-19 (SARS Co-V-2) Update: Focus on Epidemiology, Transmission, Risk Factors for Severe Illness, Persistence of Symptoms, and Vaccine Development

This course includes 1 lesson